JP2021521142A5 - - Google Patents
Info
- Publication number
- JP2021521142A5 JP2021521142A5 JP2020555239A JP2020555239A JP2021521142A5 JP 2021521142 A5 JP2021521142 A5 JP 2021521142A5 JP 2020555239 A JP2020555239 A JP 2020555239A JP 2020555239 A JP2020555239 A JP 2020555239A JP 2021521142 A5 JP2021521142 A5 JP 2021521142A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxo
- chloro
- cyclohexyl
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862654628P | 2018-04-09 | 2018-04-09 | |
| US62/654,628 | 2018-04-09 | ||
| PCT/JP2019/015392 WO2019198692A1 (en) | 2018-04-09 | 2019-04-09 | Fused cyclic urea derivatives as crhr2 antagonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521142A JP2021521142A (ja) | 2021-08-26 |
| JP2021521142A5 true JP2021521142A5 (cg-RX-API-DMAC10.html) | 2023-05-19 |
| JP7357932B2 JP7357932B2 (ja) | 2023-10-10 |
Family
ID=68164246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555239A Active JP7357932B2 (ja) | 2018-04-09 | 2019-04-09 | Crhr2拮抗薬としての縮合環状尿素誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11802120B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3774739B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7357932B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102590854B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN111868037B (cg-RX-API-DMAC10.html) |
| BR (1) | BR112020020708A8 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3094609A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2917634T3 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2020010568A (cg-RX-API-DMAC10.html) |
| TW (1) | TWI822754B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2019198692A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122023023802A2 (pt) | 2015-04-29 | 2023-12-26 | Janssen Pharmaceutica Nv | Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem |
| WO2021145401A1 (en) * | 2020-01-15 | 2021-07-22 | Raqualia Pharma Inc. | Spiroheterocyclic derivatives as crhr2 antagonist |
| EP3901152A1 (en) * | 2020-04-23 | 2021-10-27 | F. Hoffmann-La Roche AG | Kv3 enhancers for the treatment of cognitive disorders |
| CR20220565A (es) * | 2020-05-06 | 2023-01-13 | Merck Sharp & Dohme Llc | Inhibidores de il4i1 y métodos de uso |
| WO2022071484A1 (en) * | 2020-09-30 | 2022-04-07 | Raqualia Pharma Inc. | 3-hydroxyoxindole derivatives as crhr2 antagonist |
| WO2022228365A1 (zh) * | 2021-04-27 | 2022-11-03 | 南京明德新药研发有限公司 | 六元杂芳并脲环的衍生物及其应用 |
| KR20250113346A (ko) * | 2024-01-17 | 2025-07-25 | 주식회사 엘지화학 | CBP/p300 저해제로 사용되는 신규 화합물, 및 이를 유효성분으로 포함하는 암, 염증성 장애 또는 자가면역 질환의 예방 또는 치료용 약학 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3538899A (en) * | 1998-04-30 | 1999-11-23 | Nippon Chemiphar Co. Ltd. | Condensed imidazole derivative and therapeutic agent for liver disease |
| CA2446514A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| ATE397609T1 (de) * | 2001-06-12 | 2008-06-15 | Glaxo Group Ltd | Corticotropinfreisetzungsfaktor antagonisten |
| JP2007161585A (ja) * | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
| US7652035B2 (en) | 2004-10-19 | 2010-01-26 | Neurocrine Bioscience, Inc. | CRF receptor antagonists and methods relating thereto |
| US10166271B2 (en) | 2006-06-21 | 2019-01-01 | The Regents Of The University Of California | Methods for promoting hair growth |
| US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| AR080056A1 (es) * | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| JP2015516979A (ja) | 2012-04-23 | 2015-06-18 | ホルスボールマッシュマイヤー ニューロケミー ゲーエムベーハーHolsboermaschmeyer Neurochemie Gmbh | Crh過剰活性を有する患者の治療に用いるためのcrhr1アンタゴニスト |
-
2019
- 2019-04-09 MX MX2020010568A patent/MX2020010568A/es unknown
- 2019-04-09 CN CN201980019725.6A patent/CN111868037B/zh active Active
- 2019-04-09 TW TW108112345A patent/TWI822754B/zh active
- 2019-04-09 KR KR1020207030243A patent/KR102590854B1/ko active Active
- 2019-04-09 US US17/046,196 patent/US11802120B2/en active Active
- 2019-04-09 CA CA3094609A patent/CA3094609A1/en active Pending
- 2019-04-09 JP JP2020555239A patent/JP7357932B2/ja active Active
- 2019-04-09 ES ES19785626T patent/ES2917634T3/es active Active
- 2019-04-09 EP EP19785626.3A patent/EP3774739B1/en active Active
- 2019-04-09 WO PCT/JP2019/015392 patent/WO2019198692A1/en not_active Ceased
- 2019-04-09 BR BR112020020708A patent/BR112020020708A8/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530960A5 (cg-RX-API-DMAC10.html) | ||
| CN111868037B (zh) | 作为crhr2拮抗剂的稠合环状脲衍生物 | |
| HRP20200962T1 (hr) | Novi spojevi | |
| US8987301B2 (en) | Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors | |
| RU2015129538A (ru) | Замещенные имидазопиридины в качестве ингибиторов hdm2 | |
| JP5987005B2 (ja) | オレキシン拮抗薬として有用な新規なピラゾール及びイミダゾール誘導体 | |
| JP2020514267A5 (cg-RX-API-DMAC10.html) | ||
| AU2018334290A1 (en) | Pyridazinones and methods of use thereof | |
| RU2016140338A (ru) | Азаспиро производные в качестве антагонистов trpm8 | |
| RU2003107016A (ru) | Замещенные пиразолы | |
| CA2570987A1 (en) | Novel alkynyl derivatives as modulators of metabotropic glutamate receptors | |
| JP2013519724A5 (cg-RX-API-DMAC10.html) | ||
| JP2015514783A (ja) | ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用 | |
| RU2014119244A (ru) | Гетероциклические соединения и способы их использования | |
| US11814384B2 (en) | Inhibtors of Raf kinases | |
| US20240109900A1 (en) | Azabicyclic shp2 inhibitors | |
| JP2023145748A (ja) | 新規トリアゾロン誘導体またはその塩、およびこれらを含む医薬組成物 | |
| JP2021519294A5 (cg-RX-API-DMAC10.html) | ||
| US12421191B2 (en) | 3-hydroxyoxindole derivatives as CRHR2 antagonist | |
| RU2020134947A (ru) | Производные конденсированной циклической мочевины в антагонист crhr2 | |
| RU2778641C2 (ru) | Производные конденсированной циклической мочевины в антагонист crhr2 | |
| HK40043109A (en) | Fused cyclic urea derivatives as crhr2 antagonist | |
| HK40043109B (en) | Fused cyclic urea derivatives as crhr2 antagonist | |
| WO2025259929A1 (en) | COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS | |
| JPWO2024111560A5 (cg-RX-API-DMAC10.html) |